GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Mindset Pharma Inc (STU:9DF) » Definitions » EV-to-EBITDA

Mindset Pharma (STU:9DF) EV-to-EBITDA : -10.84 (As of May. 27, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Mindset Pharma EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Mindset Pharma's enterprise value is €45.88 Mil. Mindset Pharma's EBITDA for the trailing twelve months (TTM) ended in Mar. 2023 was €-4.23 Mil. Therefore, Mindset Pharma's EV-to-EBITDA for today is -10.84.

The historical rank and industry rank for Mindset Pharma's EV-to-EBITDA or its related term are showing as below:

STU:9DF's EV-to-EBITDA is not ranked *
in the Biotechnology industry.
Industry Median: 9.57
* Ranked among companies with meaningful EV-to-EBITDA only.

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-05-27), Mindset Pharma's stock price is €0.50. Mindset Pharma's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2023 was €-0.042. Therefore, Mindset Pharma's PE Ratio for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Mindset Pharma EV-to-EBITDA Historical Data

The historical data trend for Mindset Pharma's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mindset Pharma EV-to-EBITDA Chart

Mindset Pharma Annual Data
Trend Dec18 Dec19 Jun21 Jun22
EV-to-EBITDA
- - -3.74 -1.52

Mindset Pharma Quarterly Data
Dec18 Mar19 Jun19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23
EV-to-EBITDA Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.09 -1.52 -4.38 -3.72 -2.33

Competitive Comparison of Mindset Pharma's EV-to-EBITDA

For the Biotechnology subindustry, Mindset Pharma's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mindset Pharma's EV-to-EBITDA Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Mindset Pharma's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Mindset Pharma's EV-to-EBITDA falls into.



Mindset Pharma EV-to-EBITDA Calculation

Mindset Pharma's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=45.883/-4.234
=-10.84

Mindset Pharma's current Enterprise Value is €45.88 Mil.
Mindset Pharma's EBITDA for the trailing twelve months (TTM) ended in Mar. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €-4.23 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Mindset Pharma  (STU:9DF) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Mindset Pharma's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=0.50/-0.042
=At Loss

Mindset Pharma's share price for today is €0.50.
Mindset Pharma's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.042.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Mindset Pharma EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Mindset Pharma's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Mindset Pharma (STU:9DF) Business Description

Traded in Other Exchanges
N/A
Address
217 Queen Street West, Suite 401, Toronto, ON, CAN, M5V 0R2
Mindset Pharma Inc is a drug discovery and development company focused on creating psychedelic medicines to treat neurological and psychiatric disorders.

Mindset Pharma (STU:9DF) Headlines

No Headlines